Long Lasting Injectables, Shorter Path to Approval

Long Lasting Injectables, Shorter Path to Approval

Recorded On: 11/20/2024

Overview of the 2024 MIDD Webinar Series

The 2024 MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.

Emma Hughes

Pharmacometrician

Gilead Sciences

Emma received her bachelor’s degree in chemistry from Mount Holyoke College. She went on to join the National Center for Advancing the Translational Science’s DMPK group. There she performed both bioanalysis as well as determined a compound’s preclinical PK profile for small molecules. Emma received her PhD from the University of California San Francisco’s Pharmaceutical Sciences and Pharmacogenomics program where her research focused on building PK/PD models for infectious diseases in special populations, primarily malaria in pregnant women.

Key:

Complete
Failed
Available
Locked
MIDD Webinar Series | Long Lasting Injectables, Shorter Path to Approval
Recorded 11/20/2024  |  60 minutes
Recorded 11/20/2024  |  60 minutes